Kirtland Hills Capital Management’s Idexx Laboratories IDXX Stock Holding History

Kirtland Hills Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$441K	Sell	764 -189	-20%	-$121K	0.14%	121
2025 Q4	$645K	Hold	953	–	–	0.23%	99
2025 Q3	$609K	Sell	953 -13	-1%	-$7.89K	0.24%	104
2025 Q2	$518K	Sell	966 -22	-2%	-$10.5K	0.24%	108
2025 Q1	$407K	Sell	988 -89	-8%	-$38.6K	0.25%	103
2024 Q4	$445K	Buy	1,077 +18	+2%	+$7.89K	0.29%	90
2024 Q3	$535K	Hold	1,059	–	–	0.3%	85
2024 Q2	$516K	Hold	1,059	–	–	0.43%	72
2024 Q1	$515K	Buy	+1,059	New	+$579K	0.44%	72

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kirtland Hills Capital Management's IDXX Position: Q1 2026 in Review

Kirtland Hills Capital Management reduced its Idexx Laboratories (IDXX) stake by 20% in Q1 2026, selling an estimated $121K and leaving 764 shares worth $441K. The position accounts for 0.14% of the portfolio, ranked #121.

Kirtland Hills Capital Management first reported a position in IDXX in Q1 2024 and has held it in 9 quarters since. The position peaked at $645K in Q4 2025. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Kirtland Hills Capital Management held 764 shares of Idexx Laboratories worth $441K as of Q1 2026.
Kirtland Hills Capital Management sold 189 Idexx Laboratories shares in Q1 2026, an estimated $121K.
Idexx Laboratories made up 0.14% of Kirtland Hills Capital Management's portfolio in Q1 2026, its #121 holding.
Kirtland Hills Capital Management first reported a position in Idexx Laboratories in Q1 2024 and has held it in 9 quarters since.
Kirtland Hills Capital Management's Idexx Laboratories position peaked at $645K in Q4 2025.
1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Kirtland Hills Capital Management's 13F filing for Q1 2026, filed 13 May 2026.